Prevention of transmission of Hepatitis B, Hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.

Vox Sanguinis

Volumn 74, Issue SUPPL. 2, 1998, Pages 147-154

  Busch, Michael P ^a  

^a Blood Centers of the Pacific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN;

BLOOD TRANSFUSION; CONFERENCE PAPER; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SCREENING TEST; VIRUS TRANSMISSION;

EID: 0031853926     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1998.tb05413.x     Document Type: Conference Paper

References (79)

1. Lee WM. Hepatitis B virus infection. (Review Article:Medical Progress). N Engl J Med 1997;337:1733-1745.
2. Dodd RY, Popovsky MA, and members of the Scientific Section Coordinating Committee [of the AABB]. Antibodies to hepatitis B core antigen and the infectivity of the blood supply. [Committee Reports] Transfusion 1991;31:443-449. [published erratum appears in Transfusion 1991;31:594]
3. Stevens CE, Aach RD, Hollinger FB, Mosley JW, Szmuness W, Kahn R, Werch J, Edwards V. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 1984;101:733-738.
4. Hoofnagle JH, Seeff LB, Bales ZB, Zimmerman HJ. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978;298:1379-1383.
5. Mosley JW, Stevens CE, Aach RD, Hollinger FB, Mimms LT, Solomon LR, Barbosa LH, Nemo GJ. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995;35:5-12.
6. Seeff LB, Beebe GW, Hoofnagle JH, Norman JE, Buskell-Bales Z, Waggoner JG, Kaplowitz N, Koff RS, Petrini JL Jr, Schiff ER. A serologic follow-up of the 1942 post-vaccination hepatitis in the United States Army. N Engl J Med 1987;316:965-970.
7. Schmidt PJ, Leparc GF, Samia CT. Comparison of assays for anti-HBc in blood donors. Transfusion 1988;28:389-391.
8. Dodd RY. Selection of methods for HBsAg, anti-HIV and anti-HBc testing, in Dixon MR, Ellisor SS, eds. Selection of methods and instruments for blood banks. Arlington, Virginia, USA. Amer Assn of Blood Banks, 1987. pp91-108
9. Spronk AM, Schmidt L, Krenc C, Pavlis-Jenkins L, Brady J, Taskar S, Angus-Finn L, Mimms L. Improvements in detection of antibody to hepatitis B core antigen by treating specimens with reducing agent in an automated microparticle enzyme immunoassay. J Clin Microbiol 1991;29:611-616.
10. Bastiaans MJS, Nath N, Dodd RY, Barker LF, Hepatitis-associated markers in the American Red Cross volunteer blood donor populations. IV. A comparison of HBV-associated serologic markers in HBsAg-positive first-time and repeat blood donors. Vox Sang 1982;42:203-210.
11. Molijn MHJ, van der Linden JM, Ko LK, Gorgels J, Hop W, van Rhenen DJ. Risk factors and anti-HBc reactivity among first time blood donors. Vox Sang 1997;72:207-210
12. Moore MC, Godfrey GS, Hewitt PE, Barbara JAJ. Does anti-HBc reactivity reflect 'lifestyle' risk in north London blood donors? Vox Sang 1997;72:79-84.
13. Korelitz JJ, Busch MP, Kleinman SH, Williams AE, Zuck TF, Gilcher RO, Ownby HE, Co Chien H, Nemo GJ. Relationship between antibody to hepatitis B core antigen and retro- viral infections in blood from volunteer donors. Transfusion 1996;36:232-237.
14. Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadovsky R, Morrison JM, Kellner A. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980;303:833-841.
15. Levine OS, Vlahov D, Brookmeyer R, Cohn S, Nelson KE. Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users. J Infect Dis 1996;173:579-583.
16. Davaro RE, Cheeseman SH, Keroack MA, Ellison RT III. The significance of isolated antibody to hepatitis B core antigen seropositivity in patients infected with human immunodeficiency virus. [Brief Report] Clin Infect Dis 1996;23:189-190.
17. Centers for Disease Control:Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Nov 22, 1991;40(RR-13):1-25.
18. Busch MP, Dodd RY, Lackritz EM, AuBuchon JP, Birkmeyer JD, Petersen LR, and the HIV Blood Donor Study Group, Residual value and cost-effectiveness of screening blood donors for antibody to Hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. Transfusion 1997;37:1003-1011.
19. Koziol DE, Holland PV, Ailing DW, et al. Antibody to hepatitis B core antigen as a para- doxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986;104:488-495.
20. Sugg U, Schenzle D, Hess G. Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients. Transfusion 1988;28:386-388.
21. Alter HJ. Transfusion transmitted hepatitis C and non-A, non-B, non-C. (ISBT State of the Art Lecture, Amsterdam, June 1994) Vox Sang 1994;67(suppl 3):19-24.
22. Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991;325:1325-1329.
23. Dodd RY, Reesink HW, Busch MP, Petersen LR, Lackritz EM, Blajchman MA, Barbara JAJ, Kuehnl P, Knoedler B, Schonitzer D, Hogman CF, Lindholm A, Sekiguchi S, Wendel S. ISBT International Forum:Do Surrogate Tests Improve the Safety of the Blood Supply? Vox Sang 1995;69:280-291.
24. Donahue JG, Munoz A, Ness PM, Brown DE Jr, Yawn DH, McAllister HA Jr, Reitz BA, Nelson KE. The declining risk of post-transfusion hepatitis C virus infection [see comments]. N Engl J Med 1992;327:369-373.
25. Blajchman MA, Bull SB, Feinman SV. Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group [see comments]. Lancet 1995;345:21-25.
26. Anderson NAB, Raafat A, Shwe KH, Barbara J, Contreras M, Fraser ID, Gunson HH, Martlew V, Mijovic V, Goldie DJ, Seneviratne CJ, Bendle A, Briggs M, Paver K. UK multicentre study on blood donors for surrogate markers of non-A non-B hepatitis. Part I:Alanine transferase and anti-HBc testing. Transfus Med 1992;2:301-310.
27. Japanese Red Cross Non-A, Non-B Hepatitis Research Group. Effect of screening for hepatitis C virus and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Lancet 1991;338:1040-1041.
28. Goncales FL Jr., Pedro RJ, Silva LJ, Boccato RSBS, Ramos MC, Goncales NSL. Hepatites pos-transfusionais na cidade de Campinas, SP, Brazil. 1:Incidencia, agentes etiologicos e aspectos clinicos epidemilogicos de hepatite por virus. Rev Inst Med Trop Sao Paulo 1993;35:53-62.
29. Ismay SL, Thomas S, Fellows A, Keller A, Kenrick KG, Archer GT, Wylie BR, Cossart YE. Post-transfusion hepatitis revisited. Med J Australia 1995;163:74-77.
30. Jullien AM, Courouce AM, Massari V, Maniez M, Finetti P, Breviere D, Girard M, Andreani T, Habibi B. Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission. Eur J Clin Microbiol Infect Dis 1993;12:668-672.
31. Esteban JI, Camps J, Genesca J, Alter HJ. Hepatitis C and B:New Developments. in Nance ST, ed. ("Nance SN", incorrectly, in MedLine & other databases) Blood Safety: Current Challenges. Bethesda, Maryland, USA. Amer Assn of Blood Banks. 1992, pp 45-96.
32. Mosley JW, Huang W, Stram DO, Nowicki MJ, Hollinger FB, Aach RD, Stevens CE, Barbosa LH, Nemo GJ. Donor levels of serum alanine aminotransferase activity and antibody to hepatitis B core antigen associated with recipient hepatitis C and non-B, non-C out-comes. Transfusion 1996;36:776-781. Abstract erratum corrected: Transfusion 1997;37:109.
33. Infectious Disease Testing for Blood Transfusions. NIH Consensus Statement. Bethesda, Maryland, USA. US PHS, NIH. 1995 Jan 9-11, 13(1):1-27.
34. Perkins HA. Transfusion-associated AIDS. Am J Hematol 1985;19:307-313.
35. Pindyck J, Waldman A, Zang E, Oleszko W, Lowy M, Bianco C. Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion. Evidence of volunteer blood donor cooperation. Transfusion 1985;25:3-9.
36. Simon TL, Bankhurst AD. A pilot study of surrogate tests to prevent transmission of acquired immune deficiency syndrome by transfusion. Transfusion 1984;24:373-378.
37. Korelitz JJ, Busch MP, Williams AE, and the Retrovirus Epidemiology Donor Study. Antigen testing for human immunodeficiency virus (HIV) and the magnet effect: will the benefit of a new HIV test be offset by the numbers of higher-risk, test-seeking donors attracted to blood centers? Transfusion 1996;36:203-208.
38. Kern JM; Croy BB. A review of transfusion-associated AIDS litigation: 1984 through 1993 [see comments]. Transfusion 1994;34:484-491.
39. Perkins HA (San Francisco), personal communications.
40. Leitman SF, Klein HG, Melpolder JJ, Read EJ, Esteban JI, Leonard EM, Harvath L, Shih JW, Nealon R, Foy J. Clinical implications of positive tests for antibodies to human immunodeficiency virus type 1 in asymptomatic blood donors. N Engl J Med 1989;321:917-924.
41. Petersen LR, Doll LS, White CR, Johnson E, Williams A, and the HIV Blood Donor Study Group. Heterosexually acquired human immunodeficiency virus infection and the United States blood supply: considerations for screening of potential blood donors. Transfusion 1993;33:552-557.
42. Preiksaitis JK, Rivet C. A history of the evolution of hepatitis C testing of blood donors: implications for the Canadian blood supply system. Conference Report. Transfusion 1995;35:348-352.
43. Kleinman SH, Busch MP, Hall L, Thomson R, Gallahan D, Ownby HE, Williams AE, for the Retrovirus Epidemiology Donor Study. Rates and patterns of false positive Western blot results in U. S. blood donors. J Amer Med Assn, 1998 (submitted).
44. Rawal BD, Busch MP, Kleinman SH, Garrett PE, Ownby HE, Barmat S, for the REDS study. Relationship between hepatitis B virus DNA and surface antigen in acute and chronically infected blood donors. Abstract S-441. Transfusion 1997;37(9-Suppl):111s.
45. Rasenack JWF, Schlayer H-J, Hettler F, Peters T, Preisler-Adams S, Gerok W. Hepatitis B virus infection without immunological markers after open-heart surgery. Lancet 1995;345:355-357.
46. Chazouilleres O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, Sacher NL, Wright TL. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994;343:142-146.
47. Carman W, Thomas H, Domingo E. Viral genetic variation: hepatitis B virus as a clinical example. [review] Lancet 1993;341:349-353.
48. Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F, Goudeau A, Wands J, Sninsky J, Tiollais P, Brechet C. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 1988;1988ii:1273-1276.
49. Kojima M, Shimizu M, Tsuchimochi T, Koyasu M, Tanaka S, Iizuka H, Tanaka T, Okamoto H, Tsuda F, Miyakawa Y, Mayumi M. Posttransfusion fulminant hepatitis B associated with precore-defective HBV mutants. Vox Sang 1991;60:34-39
50. Jongerius JM, Wester M, Cuypers HTM, van Oostendorp WR, Lelie PN, van der Poel CL, van Leeuwen EF. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion 1998;38:56-59.
51. Hoofnagle JH. Posttransfusion hepatitis B. Transfusion 1990;30:384-386.
52. Lander JJ, Gitnick LGL, Gelb LH, Aach RD. Anticore antibody screening of transfused blood. Vox Sang 1978;34:77-80.
53. Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn RA, Stevens CE, Edwards VM, Werch J. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. The transfusion-transmitted viruses study. N Engl J Med 1981;304:989-994.
54. Chambers LA, Popovsky MA, Decrease in reported posttransfusion hepatitis. Contributions of donor screening for alanine aminotransferase and antibodies to hepatitis B core antigen and changes in the general population. Arch Intern Med 1991;151:2445-2448.
55. Nelson KE, Ahmed F, Stambolis V, Ness PM, Yawn D, McAllister H. Incident hepatitis C virus (HCV) and hepatitis B virus (HBV) infections in transfused cardiac surgery patients: infection rates during different methods of donor screening. NIH Consensus Development Conference: Infectious Disease Testing for Blood Transfusions. Jan 1995, Bethesda MD. Program and Abstracts Book: pp67-69.
56. Iizuka H, Ohmura K, Ishijima A, Satoh K, Tanaka T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992;63:107-111.
57. Hennig H, Dennin RH, Haase D, Kirchner H. [HBV-DNA positive findings in HBsAg negative blood donors and patients][German] Beitrage z. Infusionther Transfusmed 1997;34:26-30
58. Wang JT, Wang TH, Sheu JC, Shih LN, Lin JT, Chen DS. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepati- tis B surface antigen. J In feet Dis 1991;163:397-399.
59. Pao CC, Yao D-S, Lin C-Y, Kao S-M, Tsao K-C, Sun C-F, Liaw YF. Serum hepatitis B virus DNA in hepatitis B virus seropositive and seronegative patients with normal liver function. Am J Clin Pathol 1991;95:591-596.
60. Matsumoto C, Nishioka K, Oguchi T, Mitsunaga S, Nojiri N, Tadokoro K, Juji T. Detection and quantitation of HBV DNA by seminested PCR in donated blood: comparison with HBV serological markers. J Virol Meth 1997;66:61-69.
61. Gomes SA, Yoshida CF, Niel C. Detection of hepatitis B virus DNA in hepatitis B surface antigen-negative serum by polymerase chain reaction: evaluation of different primer pairs and conditions. Acta Virologica 1996;40:133-138.
62. Saraswat S, Manerjee K, Chaudhury N, Mahant T, Khandehar P, Gupta RK, Naik S. Posttransfusion hepatitis type B following multiple transfusions of HBsAg-negative blood. J Hepatoll 996;25:639-643.
63. Nagaraju K, Misra S, Saraswat S, Choudhary N, Masih B, Ramesh V, Naik S. High prevalence of HBV infectivity in blood donors detected by the dot blot hybridisation assay. Vox Sang 1994;67:183-186.
64. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nature Med 1996;2:1104-1108.
65. Douglas DD, Taswell HF, Rakela J, Rabe D. Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen posi- tive from a United States population with a low prevalence of hepatitis B serologic markers. Transfusion 1993;33:212-216.
66. Ferec C, Verlingue C, Saleum JP. HBV DNA in blood donors. [letter] Transfusion 1988;28:84-85.
67. Allain J-P, Reeves I, Kitchen AD, Wenham D, Williamson LM. Feasibility and usefulness of an efficient anti-HBc screening programme in blood donors. Transfusion Med 1995;5:259-265.
68. Scully LJ, Sung H, Pennie R, Gill P. Detection of hepatitis B virus DNA in the serum of Canadian hepatitis B surface antigen negative, anti-HBc positive individuals, using the polymerase chain reaction. J Med Virol 1994;44:293-297.
69. Liang TJ, Bodenheimer HC Jr., Yankee R, Brown NV, Chang K, Huang J, Wands JR. Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification. J Med Virol 1994;42:151-157.
70. Tegtmeier G, Henderson S, Parton P, Vance K, Edwards R, McNamara A, Kuhns M. Acute hepatitis B infection after blood transfusion is not due to occult hepatitis B infection in donors. Abstract S-440. Transfusion 1997;37(Suppl):110s.
71. Gross A, Joller-Jemelka HI, Wicki AN, Grob JP. [Hepatitis serological finding "anti-HBc alone", circulating viral DNA and interpretation of findings]. [German] Swiss Journal of Medicine 1993;123:1193-1202.
72. Zaaijer HL, ter Borg F, Cuypers HT, Hermus MC, Lelie PN. Comparison of methods for detection of hepatitis B virus DNA. J Clin Microbiol 1994;32:2088-2091.
73. Draelos M, Morgan T, Schifman RN, Sampliner RE. Significance of isolated antibody to hepatitis B core antigen determined by immune rsponse to hepatitis B vaccination. JAMA 1987;258:1193-1195.
74. Wu JS, Tam KM, Immune response to hepatitis B vaccine in subjects positive for serum hepatitis B core antibody alone. J Formosan Med Assoc 1988;87:944-946.
75. Lok ASF, Lai CL, Wu PC. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 1988;8:766-770.
76. McMahon BJ, Parkinson AJ, Helminiak C, Wainwright RB, Bulkow L, Kellerman-Douglas A, Schoenberg S, Ritter D. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen [see comments]. Gastroenterol 1992;103:590-594.
77. Aoki SK, Finegold D, Kuramoto IK, Douville C, Richards C, Randell R, Fernando L, Holland PV, Zeldis JB. Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine. Transfusion, 1993;33:362-367.
78. AuBuchon JP, Birkmeyer JD, Busch MP. Safety of the blood supply in the United States: opportunities and controversies. [Perspective] Annals Int Med 1997;127:904-909.
79. Busch MP, Stramer SL, Kleinman SH. Evolving aApplications of nucleic acid amplification assays for prevention of viral transmission by blood components and derivatives. Chapter 6 in Garratty G, ed. Applications of Molecular Biology to Blood Transfusion Medicine (1997 Workshop book). Bethesda, Maryland, USA. Amer Assn of Blood Banks, 1997, pp123-176.